Sriram Ryali - May 10, 2021 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Chief Financial Officer
Signature
/s/ Sriram Ryali
Stock symbol
EIGR
Transactions as of
May 10, 2021
Transactions value $
$0
Form type
4
Date filed
5/11/2021, 08:32 PM
Next filing
Jul 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +87K $0.00 87K May 10, 2021 Common Stock 87K $8.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments over 48 months measured from May 10, 2021 subject to Reporting Person's continuous service status as of each such date.